Senestech (NASDAQ:SNES) Stock: Insider Glenbrook Capital Management Purchases 60,000 Shares

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 60,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 21st. The stock was purchased at an average cost of $0.74 per share, with a total value of $44,400.00. Following the completion of the transaction, the insider directly owned 2,159,473 shares in the company, valued at $1,598,010.02. This represents a 2.86% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Thursday, October 22nd, Glenbrook Capital Management purchased 7,500 shares of Senestech stock. The shares were purchased at an average cost of $0.80 per share, for a total transaction of $6,000.00.
• On Tuesday, October 20th, Glenbrook Capital Management bought 36,375 shares of Senestech stock. The shares were purchased at an average cost of $0.67 per share, for a total transaction of $24,371.25.
• On Monday, October 19th, Glenbrook Capital Management acquired 376,552 shares of Senestech stock. The shares were acquired at an average price of $0.70 per share, for a total transaction of $263,586.40.
• On Friday, October 16th, Glenbrook Capital Management acquired 181,252 shares of Senestech stock. The stock was acquired at an average cost of $0.63 per share, for a total transaction of $114,188.76.
• On Thursday, October 15th, Glenbrook Capital Management acquired 426,000 shares of Senestech stock. The stock was acquired at an average cost of $0.77 per share, for a total transaction of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management acquired 6,490 shares of Senestech stock. The shares were acquired at an average price of $1.30 per share, with a total value of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management bought 15,000 shares of Senestech stock. The shares were acquired at an average cost of $1.30 per share, with a total value of $19,500.00.

Senestech Trading Up 5.1%

NASDAQ:SNES opened at $0.84 on Friday. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.78 and a quick ratio of 5.81. The firm has a 50-day moving average of $0.88 and a 200-day moving average of $1.31. The company has a market cap of $4.56 million, a PE ratio of -0.61 and a beta of 0.25. Senestech, Inc. has a one year low of $0.55 and a one year high of $3.85.

Senestech (NASDAQ:SNES) last announced its earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.37) by $0.02. The company had revenue of $0.77 million for the quarter, compared to analysts’ expectations of $0.60 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. As a group, equities research analysts expect that Senestech, Inc. will post -1.28 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Senestech stock. Diversify Wealth Management LLC acquired a new position in Senestech, Inc. (NASDAQ:SNES) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned about 0.36% of Senestech as of its most recent filing with the Securities and Exchange Commission. 5.19% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Senestech presently has an average rating of “Sell”.

About Senestech

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.